Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-01-04 @ 3:46 AM
Study NCT ID:
NCT03109093
Status:
COMPLETED
Last Update Posted:
2023-03-21
First Post:
2017-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia
Sponsor:
Goethe University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-13
First Submit QC Date:
None
Study First Post Date:
2017-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-17
Last Update Post Date:
2023-03-21
Last Update Post Date Type:
ACTUAL